Latest News of CTKB
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue Growth and Positive Net ...
By Yahoo! Finance |
3 days ago
The CEO discusses the normalized demand environment in the US, emphasizing the essential role of flow cytometry in biology labs. The CFO expects sequential revenue growth in Q4 and outlines strategies...
Cytek Biosciences, Inc. (NASDAQ:CTKB) is a favorite amongst institutional investors who own 51%
By Yahoo! Finance |
3 months ago
Ownership research and analyst forecasts provide insights into stock opportunities. Institutional investors own 51% of Cytek Biosciences, impacting its market moves. Top shareholders include BlackRock...